5/23: 11th Annual CABS Conference

8:00am – 9:00am:

Registration, networking, wake-up coffee/pastries & vendor show

9:00am – 9:10am:

Welcome & Opening Remarks (Shichang Miao, Ph.D.,  CABS)

9:10am – 9:20am:

State of the Society (Leping Li, Ph.D.,  CABS)

Plenary Session: Successes, Challenges and Opportunities of the Biotech Industry

(co-chairs: Leping Li & Shichang Miao)

9:20am – 9:50am:

Norbert Bischofberger, Ph.D. (Executive VP R&D and Chief Scientific Officer, Gilead Sciences): “Gilead Sciences: The Evolution of HIV Treatment and Gilead 's Contributions”

9:50am - 10:20am:

Nancy Chang, Ph.D. (OrbiMed Venture; Founder of Tanox):

Changing nature of Pharma R&D and Outsourcing environment in Asia

10:20am – 10:50am:

Karl Sanford, Ph.D. (VP Technology, Genencor): “Recent Developments in Industrial Biotechnology: from industrial enzymes to biochemicals to biofuels”

10:50am – 11:20am:

Break, networking & vendor show

Scientific Session: Advances in Oncology and Neuroscience R&D

(co-chairs: Charlene Liao & Wentao Zhang)

11:20am – 11:50am:

Ira Mellman, Ph.D. (Vice President, Research Oncology, Genentech):

“Oncology Research at Genentech: Where Basic Science Needs No Translation”

11:50pm – 12:20pm:

Peter Lamb, Ph.D. (Chief Scientific Officer, Exelixis): “Discovery and Development of Targeted Small Molecule Therapeutics for Oncology”

12:20pm – 1:50pm:

Lunch, Networking, Vendor Show

1:50pm – 2:20pm

Professor Dean Felsher ( Stanford University ):

“Reversing Cancer through targeted oncogene inactivation”

2:20pm – 2:50pm:

Alexander “Sasha” Kamb, Ph.D. (Neuroscience Therapeutic Area Head, Amgen):

“Problems and (possible) solutions in the neurosciences therapeutic area”

Session on China Biotechnology and Drug Development

2:50pm – 3:20pm:

Joseph McCracken, Ph.D. (Vice President, Business Development, Genentech): "Collaboration: a key to Genentech's success as the leading biotechnology company"

3:20pm – 3:40pm:

Break, networking & vendor show

Track 1

Track 2

3:40pm – 4:00pm:

Wayne Li, Ph.D. (Morningside Group): “The state and future of biotech funding in China ”

Tony Zhang, Ph.D. (Managing Director and site head,  China R&D, Eli Lilly):

“Pharmaceutical R&D Networks and NME Development Efficiency”

4:00pm – 4:20pm:

Jing-shan Hu, Ph.D. (Director Licensing & External Research, Merck): “Maintaining a competitive edge in a changing landscape”

Yingfei Wei, Ph.D. (Chief Scientific Officer, 3SBio):

“Biosimilars in China : current state and future”

4:20pm – 4:40pm:

Jintao Zhang, Ph.D. (CEO, Shanghai Medicilon): “The CRO business in China today and tomorrow”

Allan Riting Liu, Ph.D. (Shanghai Fosun Pharmaceutical Group): “Fosun Pharma and its licensing and R&D alliance strategy”

4:40pm – 4:50pm:

Presentation by Gold Sponsor: Zhangjiang Biotech & Pharma Base Development Co. Ltd.

Presentation by Gold Sponsor:

GenScript

Presentation by Gold Sponsor: AzoPharma

4:50pm – 5:00pm:

Presentation by Gold Sponsor: Pharmaron

5:00pm – 5:40pm:

Break, networking & vendor show

5:40pm – 6:00pm:

Platinum Sponsor's presentation: Taicang Science Park

6:00pm – 6:15pm:

Solo Performance: Soprano Ms. Manhua Gao (著名女高音歌唱家高曼华)

6:15pm – 7:15pm:

Banquet & Entertainment

Expert Forum & Panel Discussion

7:15pm – 9:00pm:

Topics:

• Bio/Pharma trends
• Entrepreneurship
• Managing through Mergers & Acquisitions
• Career transition and development in a challenging time

Mini Keynote: Brian Cunningham, J.D. (Senior Counsel and Co-Chair of the Life Science Group, Morrison & Foerster): “Perspective on Today's BioPharmaceutical Environment”

Distinguished Panelists / discussion focuses:

• Jin-Long Chen, Ph.D. (Founder & President, NGM Biopharmaceuticals): drug discovery entrepreneurship; managing through merger & acquisitions
• Cheni Kwok, Ph.D. (Senior Vice President, Corporate Development, Poniard Pharmaceuticals): “Dress for Success - Managing the Partnership Process”
• Jay Tong, Ph.D. (Founder & Chief Executive Officer, Allcells): Entrepreneurship and service-based business
• Larry Wang, Ph.D. (Co-Founder & President, GenScript): “Boost the Innovation Capacity by Integrating with a China Biology CRO”
• Alex Wu, Ph.D. (Co-founder & Chief Executive Officer, Crown BioScience): U.S.-China entrepreneurship
• Zhenyu Yuan, Ph.D. (Founder & Chief Executive Officer, MicuRx): U.S.-China-based drug discovery